It’s still very early and the sample size is very small -- just 18 patients -- but doctors say they’ve had a 100% success rate in treating rectal cancer with NO evidence of recurrence.Scheduled for surgery, chemotherapy, radiation -- they were all in for the fight of their lives until they got the call that they were candidates for a new immunotherapy drug called Dorstarlimab.
“It went from this terrifying experience to something -- maybe I can get through this,” one man said.Immunotherapy uses the body’s own immune system to fight cancer. This clinical trial investigated if immunotherapy alone could kill rectal cancer that had not spread in patients whose tumors contain a specific genetic mutation.Doctors said “very few” patients suffered any side effects.
The doctors behind the trial have this message: “Get tested if you have rectal cancer to see if the tumor is MMRd. No matter what stage the cancer is, we have a trial at Memorial Sloan Kettering that may help you.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2 men to row in small boat across the Atlantic from New York City to IrelandCan you imagine rowing across the Atlantic Ocean from New York City to Ireland? Two men are about to do that starting on Friday.
Source: ABC7Chicago - 🏆 284. / 63 Read more »
Source: ABC7 - 🏆 67. / 68 Read more »
Source: PopSci - 🏆 298. / 63 Read more »
Source: CBSDenver - 🏆 612. / 51 Read more »
Source: FoxBusiness - 🏆 458. / 53 Read more »
Source: NYAmNews - 🏆 269. / 63 Read more »